Future Oncology
Volume 16, 2020 - Issue 15
Open access
15,832
Views
9
CrossRef citations to date
0
Altmetric
Short Communication
Real-World Use and Acceptance of Rituximab Biosimilars in Non-Hodgkin Lymphoma in an Oncologist Network in Germany
Burkhard Otremba1 Onkologische Praxis Oldenburg/Delmenhorst,Oldenburg,GermanyCorrespondence[email protected]
View further author information
, View further author information
Jens Borchardt2 Onkotrakt AG,Hamburg,GermanyView further author information
, Andra Kuske3 Medical Oncology,Hexal AG,Holzkirchen,GermanyView further author information
, Maike Hollnagel-Schmitz3 Medical Oncology,Hexal AG,Holzkirchen,GermanyView further author information
& Florian O Losch3 Medical Oncology,Hexal AG,Holzkirchen,GermanyView further author information
Pages 1001-1012
|
Received 02 Mar 2020, Accepted 25 Mar 2020, Published online: 14 Apr 2020
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.